We will continue our studies on factors influencing in vivo pathogenesis and tissue specific infection by Moloney murine leukemia virus (M-MuLV), which induces T-lymphoma in mice. These experiments will exploit novel LTR variants of M-MuLV that show altered disease patterns or tissue distributions. There are three major aims: 1) Studies on MCFs and preleukemic events induced by M-MuLV. Comparisons between wild-type and poorly leukemogenic Mo+PyF1O1 M-MuLV identified a preleukemic state of generalized hematopoietic hyperplasia in the spleen. This preleukemic state involves MCF recombinant viruses. In tile proposed experiments, we will study events involved in MCF formation in vivo. We will identify cells in the mouse involved in both MCF generation and propagation by a combination of virological and immunological approaches. The validity of these results will be tested by studying animals infected with Mo+PyF101 M-MULV, since they do not develop MCFs in vivo. The molecular basis for the inability of Mo+PyF101 MCFs to propagate in vivo will be studied. 2) Leukemogenesis by enhancer variants of M-MuLV. In contrast to wildtype M-MuLV, Delta Mo+SV M-MuLV induces B-lymphoma with extremely long latency. The mechanisms of leukemogenesis will be studied, including virological parameters, and activation of proto-oncogenes. The possibility of novel activated proto-oncogenes will be tested by PCR cloning. Sublethal irradiation markedly accelerates leukemogenesis by Delta Mo + SV M-MuLV, and the mechanism of this will be explored. A second virus, Delta 27A M-MuLV induces leukemia of diverse types, including T-lymphoid, B-lymphoid, myeloid and erythroid. Leukemogenesis by this virus will be explored as well. 3) Tissue distribution of Delta Mo+TTR(PD) M-MuLV. This virus is driven by regulatory elements of the mouse transthyretin (TTR) gene. It shows novel expression sites in vivo: the brain and (in some animals) the liver. The particular brain cells infected will be identified, and we will also seek co-factors for virus expression in the liver. These experiments will provide insight into the multi-step leukemogenic process from M-MuLv, they may also elucidate factors involved in tissue-specific virus infection in vivo.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032455-14
Application #
2088341
Study Section
Experimental Virology Study Section (EVR)
Project Start
1982-02-01
Project End
1996-01-31
Budget Start
1994-02-01
Budget End
1995-01-31
Support Year
14
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Low, Audrey; Datta, Shoibal; Kuznetsov, Yurii et al. (2007) Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release. J Virol 81:3685-92
Jahid, Sohail; Bundy, Linda M; Granger, Steven W et al. (2006) Chimeras between SRS and Moloney murine leukemia viruses reveal novel determinants in disease specificity and MCF recombinant formation. Virology 351:7-17
Kuznetsov, Y G; Low, A; Fan, H et al. (2005) Atomic force microscopy investigation of isolated virions of murine leukemia virus. J Virol 79:1970-4
Kuznetsov, Y G; Low, A; Fan, H et al. (2004) Atomic force microscopy investigation of wild-type Moloney murine leukemia virus particles and virus particles lacking the envelope protein. Virology 323:189-96
Datta, S; Kothari, N H; Fan, H (2001) Induction of Tax i expression in MT-4 cells by 5-azacytidine leads to protein binding in the HTLV-1 LTR in vivo. Virology 283:207-14
Granger, S W; Fan, H (2001) Purification of Moloney murine leukemia virus chromatin from infected cells by an affinity method. J Biomed Sci 8:278-89
Bonzon, C; Fan, H (2000) Moloney murine leukemia virus-induced tumors show altered levels of proapoptotic and antiapoptotic proteins. J Virol 74:8151-8
Datta, S; Kothari, N H; Fan, H (2000) In vivo genomic footprinting of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat enhancer sequences in HTLV-1-infected human T-cell lines with different levels of Tax I activity. J Virol 74:8277-85
Okimoto, M A; Fan, H (1999) Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice. J Virol 73:2509-16
Bundy, L M; Fan, H (1999) Molecular and phylogenetic analysis of SRS 19-6 murine leukemia virus. Virus Genes 18:65-79

Showing the most recent 10 out of 46 publications